DrugCombination product
Octenidine clinical trials
Keep track of what changes. Save the octenidine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
Bezmialem Vakif University (1) · Schülke & Mayr GmbH (1) · University Hospital Freiburg (1) · Queen Mary University of London (1)
Often tested with
Tested in the same studies.
1-Propanol (1) · 2-Propanol (1) · Ethanol (1) · Hyaluronic Acid (1)
Studies
Open first, then newest update. How each study uses octenidine is read from its arms, and is right about nine times in ten.
Testing it · 4
- Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal TreatmentRecruitingNot applicableQueen Mary University of LondonNCT06522438Written as Hyaluronic Acid (HA) and Octenidine gel
- The Effect of Using Octenidine Hydrochloride as a Final Irrigation Solution on Teeth With Asymptomatic Apical Periodontitis on Postoperative Pain and Treatment Success: A Prospective Randomized Clinical StudyCompletedNot applicableBezmialem Vakif UniversityNCT07173725Written as Octenidine dihydrochloride 0.1%
- Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to PlaceboCompletedPhase 2Schülke & Mayr GmbHNCT02138552Written as Octenidine dihydrochloride
- Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine DihydrochlorideCompletedPhase 4University Hospital FreiburgNCT00515151Written as 0.1% Octenidine with 30% 1-propanol and 45% 2-propanol
As the comparator · 3 — what is tested is compared with octenidine
- Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea PedisCompletedPhase 2Almirall, S.A.NCT01096472Written as LAS189962
- Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida InfectionsCompletedPhase 2Almirall, S.A.NCT01102387Written as LAS189962
- Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected EczemaCompletedPhase 2Almirall, S.A.NCT01020994Written as LAS189962
Codes
What other systems call octenidine · ClinicalTrials.gg INT003023
- MeSH (NLM) C034213octenidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) OZE0372S5AOCTENIDINEConfirmed FDA, NLM, Wikidata
- RxNorm 2119240Confirmed FDA, Wikidata
- Wikidata Q27285931octenidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174821OctenidineConfirmed FDA, Wikidata
- DrugBank DB12624One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C034213 | octenidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | OZE0372S5A | OCTENIDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2119240 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27285931 | octenidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174821 | Octenidine | Confirmed FDA, Wikidata |
| DrugBank | DB12624 | — | One source Wikidata |
Also registered as octenidine hydrochloride (UNII U84956NU4B · RxNorm 2119239) and octenidine saccharin (UNII R337868TDW).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.